loader image
Saturday, February 22, 2025
43.2 F
McAllen
We Welcome your Press Release
- Advertisement -

Dance Social For Cancer Patients, Survivors and Caregivers

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

Renaissance Cancer Foundation and Rhythm Room will be hosting a Dance Social to celebrate the cancer heroes in our community

Edinburg, TX- 06/20/2014- This dance social to celebrate the triumphs of cancer patients, survivors, and their caregivers is set to be an evening of joy through music and dance. Attendees will have an opportunity to dance to the rhythms of salsa, bachata, country, merengue and other latin genres. Participants will first learn basic steps taught by the professional and experienced instructors of the Rhythm Room dance studio, and will finish the night putting in some fun into those steps as they dance and practice what they learned. Our guests will also get a chance to mingle and network with others who have experienced cancer in their lives as they encourage each other and have a good time. Entrance is free and refreshments will be provided.

The dance social will take place on Friday, September 19 from 6:00 pm to 8:00 pm at the Rhythm Room studio located on 5401 N. 10th street, Suite 215, McAllen, TX.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

UPDATE: Measles Outbreak

Mega Doctor News Mega Doctor News  As of February 18, 2025, the Texas...

DHR Health Celebrates 100th Ion Robotic-Assisted Bronchoscopy

DHR Health, a leader in healthcare serving the Rio Grande Valley, announced today that Dr. Federico Vallejo, pulmonologist, has successfully performed his 100th Ion robotic-assisted bronchoscopy.

DHR Health: Pioneering Alzheimer’s Treatment Breakthrough South of San Antonio

DHR Health, a leader in healthcare innovation, proudly announced today its groundbreaking achievement as the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved medication for the early treatment of Alzheimer’s disease. This milestone demonstrates their expertise and is a significant advancement in healthcare for the Rio Grande Valley.

FDA Approves First CRISPR Gene Therapy to Treat Sickle Cell Disease

Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older.
- Advertisement -
×